GEHC’s unwarranted post-earnings plunge is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…
Fed decision, oil plunge, mixed earnings — what to watch into market close
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…
Nvidia stomps the bears. Jim Cramer on struggling stocks Starbucks, Abbott
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…
Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…
Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…
Ford, Disney, Costco and more — Jim Cramer provides his updated views on each
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…